In patients with gastrointestinal cancers treated with fluoropyrimidine-based chemotherapy agents, better overall survival at 1 year offsets a small increase in their risk of CV events, new data ...

Clinicians need to address maternal health at all stages, with some seeing a possible new role for GLP-1 drugs.

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.